Background to the therapeutic potential of essential amino acid analogues
Abstract:
Experimental investigation of the metabolic effects of essential amino acid analogues has to be critically assessed against a background of limited experimental techniques and very incomplete understanding of both protein metabolism and protein requirements. Although interest in the therapeutic use of these compounds initially centered on patients with chronic renal failure, their therapeutic potential is by no means confined to renal disease. The fact that metabolic effects of essential amino acid analogues cannot be explained simply in terms of their conversion to the essential amino acids raises the possibility that they may prove to be useful inducers of protein anabolism. Improvement in nitrogen balance may only be of the order of a few grams and measurable nitrogen balance is only a small proportion of total protein turnover, nevertheless, small changes may prove to be of considerable clinical significance.
More Related Videos
11:51Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
Published on: April 27, 2018
08:14Extraction of Non-Protein Amino Acids from Cyanobacteria for Liquid Chromatography-Tandem Mass Spectrometry Analysis
Published on: December 9, 2022
Related Concept Videos
Amino acids
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drugs Affecting Neurotransmitter Synthesis
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Amino Acid Biosynthetic Pathways
